AbbVie to Present Data From its Robust Migraine Portfolio at the Migraine Trust International Symposium 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium...
Source: prnewswire.com